Seeing the importance of the CD8+ cells against nucleocapsid in an adequate immune response against SARS-CoV-2, it is hypothesized that the inadequacy of humoral immunity, i.e., the low titer of antibodies against nucleocapsid, also draws attention to the inadequate immune response and consequently may be a cause of persistent symptoms after COVID-19. This evidence concerns the gene CD8A and COVID-19.